News &amp; Updates

Laparoscopic tubal reanastomosis yields better pregnancy outcomes and may be more cost-effective than in-vitro fertilization (IVF) treatment in women who wish to conceive after tubal ligation surgery, according to a Singapore study.

Laparoscopic tubal reversal surgery better than IVF in women with previous tubal ligation

Instead of being spontaneous, a regular habit is important for restful sleep during Ramadan.

COVID-19’s disruptive effects—working and studying from home, and social distancing, will contribute to changes in sleep patterns and on how Ramadan is practiced this year, says an expert.

Instead of being spontaneous, a regular habit is important for restful sleep during Ramadan.

COVID-19: Pharmacotherapy in Asia

Representatives from five Asian countries shared local experiences and current protocols for pharmacotherapy in treating patients with COVID-19 at a recent Asian Young Pharmacists' Group (AYPG) webinar.

COVID-19: Pharmacotherapy in Asia

COVID-19: 12 weeks in Malaysia

With daily life today upturned to a previously unthinkable extent by COVID-19, we take a brief look back at the pandemic’s march through the country in the 3 months since its arrival.

COVID-19: 12 weeks in Malaysia

Adjuvant HPV vaccine could reduce CIN2+ recurrence risk

27 Apr 2020 by

Receipt of an adjuvant human papillomavirus (HPV) vaccine following surgical excision could reduce the risk of cervical intraepithelial neoplasia (CIN2+) recurrence, according to a systematic review and meta-analysis submitted for presentation at SGO 20/20.

Adjuvant HPV vaccine could reduce CIN2+ recurrence risk

Adjunctive brivaracetam safe, effective for long-term treatment of patients with epilepsy

Long-term use of brivaracetam as an adjunctive treatment is well tolerated and effective in patients with focal seizures or primary generalized seizures, as shown in a study.

Adjunctive brivaracetam safe, effective for long-term treatment of patients with epilepsy

MIMS to host COVID-19 webcast with experts

MIMS, Asia’s medical news and communications leader, will host a COVID conversations series for primary care physicians via a live webcast titled COVID-19: What it means to your clinic.

MIMS to host COVID-19 webcast with experts

27 Apr 2020

Tanezumab for difficult-to-treat OA makes good in phase III trial

27 Apr 2020 by

Treatment with subcutaneous tanezumab 5 mg yields significant improvements in pain, physical function and PGA-OA in patients with moderate-to-severe osteoarthritis (OA) who have not responded to or could not tolerate standard-of-care analgesics, according to the results of a phase III trial.

Tanezumab for difficult-to-treat OA makes good in phase III trial

Bortezomib for maintenance, consolidation ups survival in multiple myeloma

Bortezomib-based consolidation and maintenance therapies for multiple myeloma improve survival but come with safety concerns, reports a recent meta-analysis.

Bortezomib for maintenance, consolidation ups survival in multiple myeloma

Intravesical gemcitabine, docetaxel effective for recurrent nonmuscle invasive bladder cancer

Intravesical gemcitabine and docetaxel is an effective and well-tolerated rescue therapy, delivering a durable response in patients with recurrent nonmuscle invasive bladder cancer and a history of bacillus Calmette-Guérin treatment, a recent study has shown.

Intravesical gemcitabine, docetaxel effective for recurrent nonmuscle invasive bladder cancer